Use of pemirolast in the treatment of acute asthma

Abstract

According to the invention there is provided pemirolast, or a pharmaceutically acceptable salt thereof, for use in the therapeutic treatment of asthma, such as an acute asthma attack. Suitable lower doses of pemirolast are least about 110 mg per day.

1 - 4 . (canceled) 
     
     
         5 . A method for the therapeutic treatment of asthma, which method comprises the administration of pemirolast, or a pharmaceutically acceptable salt thereof, to a patient in need of such treatment. 
     
     
         6 . A method for the treatment of asthma, which method comprises the administration of pemirolast, or a pharmaceutically acceptable salt thereof at a dose of at least about 110 mg per day (calculated as the free acid) to a patient in need of such treatment. 
     
     
         7 . A method according to  claim 5 , wherein the dose of pemirolast (calculated as the free acid) is at least about 110 mg per day. 
     
     
         8 . The method according to  claim 5 , wherein the asthma is acute asthma. 
     
     
         9 . The method according to  claim 8 , wherein the asthma comprises an acute asthma attack. 
     
     
         10 . The method according to  claim 9 , wherein the asthma is status asthmaticus. 
     
     
         11 - 12 . (canceled) 
     
     
         13 . A method of using pemirolast as a bronchodilator, which method comprises the administration of pemirolast, or a pharmaceutically acceptable salt thereof, to a patient. 
     
     
         14 . The method according to  claim 5 , wherein the patient is already receiving asthma treatment. 
     
     
         15 . The method according to  claim 6 , wherein the asthma is acute asthma. 
     
     
         16 . The method according to  claim 15 , wherein the asthma comprises an acute asthma attack. 
     
     
         17 . The method according to  claim 16 , wherein the asthma is status asthmaticus. 
     
     
         18 . The method according to  claim 6 , wherein the patient is already receiving asthma treatment. 
     
     
         19 . The method according to  claim 13 , wherein the patient is already receiving asthma treatment.